Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

Exclusion Criteria

• •Tension headache more than 5 days a month in the preceding year.
• •All other primary headache types.
• •Headache on the examination day or within 48 hours before infusion of the study drug.
• •Smoking.
• •Daily intake of medicine of any kind except for peroral contraceptives.
• •Women, who on the day of examination is 2 days before or 3 days from the first day of bleeding.
• •Hypertension or hypotension.
• •Coronary heart disease of any kind, as well as cerebrovascular disease.
• •Pulmonary disease.
• •Allergy to contents in the study drug.
• •Psychiatric disease or substance abuse.
• •Disease of any kind which the examining doctor deems relevant for participation in the study.
• •Renouncing the right to information concerning own health.
• •Criteria for the migraine patients group
• •Tension headache more than 5 days a month in the preceding year.
• •All other primary headache types.
• •Headache on the examination day or within 48 hours before infusion of the study drug.
• •Smoking.
• •Daily intake of medicine of any kind except for peroral contraceptives.
• •Women, who on the day of examination is 2 days before or 3 days from the first day of bleeding.
• •Hypertension or hypotension.
• •Coronary heart disease of any kind, as well as cerebrovascular disease.
• •Pulmonary disease.
• •Allergy to contents in the study drug.
• •Psychiatric disease or substance abuse.
• •Disease of any kind which the examining doctor deems relevant for participation in the study.
• •Renouncing the right to information concerning own health.